Abbexa
![]() |
||
Abbexa es una empresa biotecnológica especializada en reactivos de investigación fiables y de alta calidad para la investigación científica. Aportando una fuente integrada de anticuerpos, proteínas, kits ELISA y otros reactivos biológicos, la Compañía ofrece soporte técnico experto, asegurando una excelente calidad a través de una extensa validación.
Página web : www.abbexa.com
|
![SARS-CoV-2 - ELISA kits - Antibodies - IgG](https://www.clinisciences.com/es/upload/thumbs/condi-19-antibodies-qt3smg-066da6.jpg)
SARS-CoV-2 - ELISA kits - Antibodies - IgG
The newly identified coronavirus, SARS-CoV-2 (2019-nCoV), led to pneumonia (COVID-19). SARS-CoV-2 belongs to the genus of beta coronaviruses, which also includes the SARS CoV (2003) and the MERS CoV (2012). Like all other coronaviruses, the SARS-CoV-2 genome (2019-nCoV) codes for the spike protein, envelope protein, membrane protein and nucleocapsid protein.
During a viral infection, the immune system sets out to fight it through several pathways.
The immune response pattern against CoV-2-SARS is as follows. IgM antibody levels begin to rise about a week after the initial infection, while IgG antibodies appear later than IgM antibodies (usually within 14 days of infection) and may last 6 months to several years, which means that IgG antibodies serve as an indicator of a previous infection. Patients who are infected with SARS-CoV-2 can be quickly identified by simultaneous IgM and IgG monitoring.
Our ELISA kits can detect IgM and/or IgG directed against SARS-CoV-2 antigens.
Resultados de su búsqueda : 3 Producto encontrado
Refine su búsqueda :
RUOCE / IVD
- ELISA/ELISPOT
- ELISA 3
Referencia
Descripción
Cond.
Precio Sin IVA
‹
›